Skip to main content
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. logo

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. — Investor Relations & Filings

Ticker · 2395 ISIN · JP3379950003 LEI · 529900C10QR47J2U5R44 T Professional, scientific and technical activities
Open in API
Filings indexed 68 across all filing types
Latest filing 2026-05-29 Notice of Dividend Amou…
Country JP Japan
Listing T 2395

About SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.

https://en.snbl.com/

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a contract research organization (CRO) providing comprehensive drug development services. Established in 1957 as Japan's first CRO, the company supports pharmaceutical clients throughout the development lifecycle, from preclinical safety studies to clinical trial management. SNBL offers a full suite of services, including safety assessments and clinical data management. A key area of innovation is its proprietary nasal drug delivery technology, SMART (Simple MucoAdhesive Release Technology). The company's mission is to contribute to medical advancement and alleviate patient suffering by supporting the creation of new pharmaceuticals.

Recent filings

Filing Released Lang Actions
剰余金の配当（期末配当）に関するお知らせ
Notice of Dividend Amount Classification · 92% confidence The document is a formal announcement dated May 29, 2026 from the board of 株式会社 新日本科学 regarding the year-end dividend (“期末配当”) for the fiscal year ended March 31, 2026. It provides detailed dividend per share, total amount, record date, payment date, and basis for the dividend decision. This fits the definition of a Notice of Dividend Amount (DIV).
2026-05-29 Japanese
定款の一部変更に関するお知らせ
Regulatory Filings
2026-04-30 Japanese
代表取締役の異動および役員人事について
Regulatory Filings
2026-04-30 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の５の２第１項' (Article 24-5-2, Paragraph 1 of the Financial Instruments and Exchange Act). It serves as an officer certification confirming the accuracy of the contents of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a specific report type (in this case, a semi-annual report), should be classified as Regulatory Filings (RNS) rather than the report itself. H1 53
2025-11-07 Japanese
半期報告書－第53期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Shin Nippon Biomedical Laboratories, Ltd. in Japan. It contains detailed financial statements, management analysis (MDA), and business performance metrics for the interim period (April 1, 2025, to September 30, 2025). This document is a formal regulatory filing required under the Financial Instruments and Exchange Act of Japan, which corresponds to the 'Interim / Quarterly Report' category in the provided schema. H1 2026
2025-11-07 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being filed because resolutions were passed at the Annual General Meeting (定時株主総会) held on June 27, 2025, pursuant to Japanese financial regulations (FSA Order Article 19, Paragraph 2, Item 9-2). Section 2 details the resolutions, which include the election of directors and the revision of director compensation. This structure—reporting the results of a shareholder meeting (specifically the AGM) immediately after it occurs—is characteristic of reporting the outcome of the Annual General Meeting. Since the content is the official results and details of the AGM resolutions, the most appropriate classification is AGM Information (AGM-R). It is not a general proxy solicitation (PSI) or a general regulatory filing (RNS), as it is highly specific to the AGM outcome.
2025-06-30 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.